PHIO
Phio Pharmaceuticals CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.43M
P/E Ratio
—
EPS
$-1.38
Beta
0.84
52W High
$3.48
52W Low
$0.81
50-Day MA
$1.16
200-Day MA
$1.42
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.31
PEG Ratio
—
About Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-4.62M |
| EBITDA | $-11.51M |
| Operating Margin | 0.00% |
| Return on Equity | -76.40% |
| Return on Assets | -46.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.42 |
| Price-to-Book | 0.76 |
| Price-to-Sales (TTM) | 48.01 |
| EV/Revenue | 172.2 |
| EV/EBITDA | 0.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $11.62M |
| Float | $11.55M |
| % Insiders | 1.93% |
| % Institutions | 10.82% |
Historical Volatility
HV 10-Day
47.32%
HV 20-Day
42.15%
HV 30-Day
45.80%
HV 60-Day
45.46%
HV Rank
5.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($14.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026